Discover NDD with Generalized Epilepsy (NDDwGE), an SCN8A phenotype characterized by developmental challenges alongside seizures, yet with a promising outlook for advancement.
Home ➔ Diagnosis & Treatment of SCN8A ➔ SCN8A Phenotypes ➔ NDD with Generalized Epilepsy
NDD with Generalized Epilepsy (NDDwGE) is a SCN8A phenotype where individuals experience mild to moderate developmental challenges, including speech and communication delays, intellectual disabilities, and sleep disturbances. Unlike the more severe DEE, symptoms in NDDwGE are less intense and show a higher likelihood of improvement. Clinician consensus highlights a cautiously optimistic prognosis, with a significant portion of affected individuals witnessing progress over time.
Seizure Onset | 24 - 48 Months | |
Developmental Delay Onset | 12 - 60 Months | |
Seizure Types | Absence, Generalized Tonic-Clonic | |
Clinical Features | Delayed Language, Some Cognitive Understanding | |
Seizure Freedom | Some/Most of the Time | |
Prognosis | Limited Change to Improvement |
Seizure Onset
24 – 48 Months
Developmental Delay Onset
12 – 60 Months
Seizure Types
Absence, Generalized Tonic-Clonic
Clinical Features
Delayed Language, Some Cognitive Understanding
Seizure Freedom
Some/Most of the Time
Prognosis
Limited Change to Improvement
Optimal first-line medications | Valproate, Ethosuximide, Lamotrigine |
Medications to be cautious of | Sodium Channel Blockers |
Important considerations | Ketogenic diet can be helpful |
Rescue Medication | IV phenytoin or phenytoin are recommended for status epilepticus |
⯆ Keep Exploring ⯆
Home ➔ Diagnosis & Treatment of SCN8A ➔ SCN8A Phenotypes ➔ NDD with Generalized Epilepsy
IMPORTANT: While this consensus data provides new and valuable insights about best practices in the diagnosis and treatment of SCN8A, this is not medical advice. It can inform clinicians and caregivers alike in developing optimal treatment plans for each individual.